Taysha Gene Therapies, Inc. TSHA Proceeds From Issuance Of Warrants
Proceeds From Issuance Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s proceeds from issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s proceeds from issuance of warrants?
- Taysha Gene Therapies, Inc. (TSHA) reported proceeds from issuance of warrants of $56.25K in Q4 2025.
- What does proceeds from issuance of warrants mean?
- This captures the cash received from the sale or issuance of warrants, which grant the holder the right to purchase company stock at a specified price. These instruments are often used as 'sweeteners' to attract investors to debt or equity offerings. It reflects an alternative method of raising capital that may result in future share dilution.